AllianceBernstein’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $28.9K | Hold |
|
|||||
|
2025
Q2 | $21.6K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $74.9K | Hold |
|
|||||
|
2023
Q4 | $63.4K | Hold |
|
|||||
|
2023
Q3 | $414K | Hold |
|
|||||
|
2023
Q2 | $626K | Hold |
|
|||||
|
2023
Q1 | $489K | Hold |
|
|||||
|
2022
Q4 | $951K | Buy |
|
|||||
|
2022
Q3 | $726K | Hold |
|
|||||
|
2022
Q2 | $644K | Buy |
|
|||||
|
2022
Q1 | $721K | Buy |
|
|||||
|
2021
Q4 | $474K | Buy |
|
|||||
|
2021
Q3 | $500K | Hold |
|
|||||
|
2021
Q2 | $488K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $57K | Hold |
|
|||||
|
2019
Q4 | $104K | Hold |
|
|||||
|
2019
Q3 | $60K | Hold |
|
|||||
|
2019
Q2 | $121K | Buy |
|
|||||
|
2019
Q1 | $285K | Buy |
|
|||||
|
2018
Q4 | $292K | Buy |
|
|||||
|
2018
Q3 | $449K | Buy |
|
|||||
|
2018
Q2 | $575K | Buy |
|
|||||
|
2018
Q1 | $413K | Buy |
|
|||||
|
2017
Q4 | $481K | Hold |
|
|||||
|
2017
Q3 | $503K | Hold |
|
|||||
|
2017
Q2 | $529K | Buy |
|
|||||
|
2017
Q1 | $277K | Buy |
|
|||||
|
2016
Q4 | $204K | Buy |
|